Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Making better influenza virus vaccines?

Palese P.

Emerg Infect Dis. 2006 Jan;12(1):61-5. Review.

2.

[Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines].

Merkulov VA, Lebedev VN, Plekhanova TM, Maksimov VA, Korovkin SA, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2009 Mar-Apr;(2):111-7. Review. Russian.

PMID:
19462520
3.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

PMID:
18948744
5.

Current status and progress of prepandemic and pandemic influenza vaccine development.

Leroux-Roels I, Leroux-Roels G.

Expert Rev Vaccines. 2009 Apr;8(4):401-23. doi: 10.1586/erv.09.15. Review.

PMID:
19348557
6.

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.

Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, Honorkiewicz A, Rock MT, Edwards KM, Del Giudice G, Rappuoli R, Golding H.

Sci Transl Med. 2010 Jan 20;2(15):15ra5. doi: 10.1126/scitranslmed.3000624.

7.

Strategies for developing vaccines against H5N1 influenza A viruses.

Horimoto T, Kawaoka Y.

Trends Mol Med. 2006 Nov;12(11):506-14. Epub 2006 Sep 29. Review.

PMID:
17011235
8.

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Cinatl J Jr, Michaelis M, Doerr HW.

Med Microbiol Immunol. 2007 Dec;196(4):213-25. Epub 2007 Jun 1. Review.

PMID:
17541633
9.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
10.

Influenza A viruses: why focusing on M2e-based universal vaccines.

Ebrahimi SM, Tebianian M.

Virus Genes. 2011 Feb;42(1):1-8. doi: 10.1007/s11262-010-0547-7. Epub 2010 Nov 17. Review. Erratum in: Virus Genes. 2011 Feb;42(1):9.

PMID:
21082230
11.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
12.

Influenza vaccines: the good, the bad, and the eggs.

Schultz-Cherry S, Jones JC.

Adv Virus Res. 2010;77:63-84. doi: 10.1016/B978-0-12-385034-8.00003-X. Review.

PMID:
20951870
13.

Aflunov(®): a prepandemic influenza vaccine.

Gasparini R, Amicizia D, Lai PL, Panatto D.

Expert Rev Vaccines. 2012 Feb;11(2):145-57. doi: 10.1586/erv.11.170. Review.

PMID:
22309663
14.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216
15.

Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.

Shi J, Wen Z, Guo J, Zhang Y, Deng G, Shu Y, Wang D, Jiang Y, Kawaoka Y, Bu Z, Chen H.

Antiviral Res. 2012 Mar;93(3):346-53. doi: 10.1016/j.antiviral.2012.01.001. Epub 2012 Jan 18.

PMID:
22281419
16.

[Development of influenza vaccines against pandemics].

Itamura S.

Nihon Rinsho. 2000 Nov;58(11):2321-6. Review. Japanese.

PMID:
11225324
17.

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

Keitel WA, Atmar RL.

Curr Opin Pharmacol. 2007 Oct;7(5):484-90. Epub 2007 Jul 17. Review.

PMID:
17644429
18.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.

PMID:
17050041
19.

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

Wood JM, Robertson JS.

Nat Rev Microbiol. 2004 Oct;2(10):842-7. Review.

PMID:
15378048
20.

Influenza A (H5N1) pandemic prototype vaccine Fluval.

Vajo Z.

Expert Rev Vaccines. 2009 May;8(5):619-24. doi: 10.1586/erv.09.25. Review.

PMID:
19397418

Supplemental Content

Support Center